Toong-Hua LIANG (2020) “Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial”, Archives of Rheumatology, 35(2), pp. 170–179. doi: 10.46497/ArchRheumatol.2020.7464.